As such, in the instance of cancer, where PLK1 is often both overexpressed and overactive, inactivating PLK1-p53 interactions may impair cooperative p53-FOXO3a interactions and/or the concomitant repression of FOXM1. The gene discussed is PLK1; the disease is cancer.